Versican Plus Pi/L4R

Authorised

This medicine is authorised for use in the European Union

canine parainfluenza virus, leptospira and rabies virus

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Versican Plus Pi/L4R : EPAR - Summary for the public

Product information

Versican Plus Pi/L4R : EPAR - Product Information

Versican Plus Pi/L4R : EPAR - All Authorised presentations

Product details

• Name of medicine:
  Versican Plus Pi/L4R
• Active substance:
  canine parainfluenza virus, leptospira and rabies virus.
• International non-proprietary name (INN) or common name:
  canine parainfluenza virus, leptospira and rabies virus

Pharmacotherapeutic group

• Immunologicals for canidae
• Live and inactivated viral and bacterial vaccines

Authorisation details

• EMA product number:
  EMEA/V/C/003682

Assessment history

Changes since initial authorisation of medicine

Versican Plus Pi/L4R : EPAR - Procedural steps taken and scientific information after authorisation

Initial marketing authorisation documents

Versican Plus Pi/L4R : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Versican Plus Pi/L4R

Adopted Reference Number: EMA/CVMP/301696/2014